We are proud to announce that Chengdu Clement Pharmaceuticals’ invention patent, titled "A Preparation Method for an Intermediate of Etomidate", has successfully passed the substantive examination by the China National Intellectual Property Administration (CNIPA) and has been officially granted! This significant achievement marks the recognition of our company's innovative capabilities and technical expertise in pharmaceutical R&D by national authorities.
This authorized invention patent not only demonstrates our breakthrough in the preparation technology of etomidate intermediates but also lays a solid foundation for future product development and production. We will continue to uphold our spirit of innovation, driving advancements in pharmaceutical technology and contributing to industry progress and human health.
We extend our heartfelt gratitude to our dedicated team members and valued partners for their unwavering support! Moving forward, we remain committed to deepening our research in the pharmaceutical field and delivering more innovative achievements to benefit society.
简体中文
English